Several coronavirus disease 2019 (COVID-19) vaccines have received emergency use authorization (EUA) from various regulatory bodies around the world. Of these includes the messenger ribonucleic acid (mRNA) vaccine BNT162b2 that was developed by BioNTech/Pfizer. The BNT162b2 vaccine can effectively protect…